Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000217

Director sold 1,020 shares at $30.00 ($30,600)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-07 Sale : show line 1 in the form 10b5-1 −1,020 $30.00 $30,600 111,056 D
Open-market sales · 1,020 sh · avg $30.00 · $30,600
Loading xslF345X05/wk-form4_1731447801.xml…